Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
Status:
Recruiting
Trial end date:
2024-09-15
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the tolerability of the new formulation of
Dorzolamide+Timolol preservative free developed in OSD Aptar Pharma multidose system in
comparison with Dorzolamide +Timolol BAK preserved ophthalmic formulation.